When Distribution Models ​Change Faster Than Controls:​ GLP-1, DTC, and the New Pharmaceutical Risk Landscape​

Within this slide deck, you can explore how GLP-1 demand, telehealth, digital pharmacies, and direct-to-consumer distribution are reshaping the pharmaceutical supply chain and creating new patient safety and security challenges. Rx-360’s Ryan Kelly, Interim CEO and Senior Director of Supply Chain Security and Brand Protection, developed this resource, so you can be aware of emerging risks—including counterfeiting, diversion, freight fraud, and traceability gaps—and be informed of how your organization can leverage DSCSA, data quality, and supply chain intelligence to strengthen resilience in an increasingly complex distribution environment.

Join the effort to track changes and harmonize management approaches across the industry. Submit your interest in the Direct-to-Consumer Pharmaceutical Programs Working Group.